Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Biomacromolecules|March 24, 2016
A Nanoparticle Platform To Evaluate Bioconjugation and Receptor-Mediated Cell Uptake Using Cross-Linked Polyion Complex Micelles Bearing Antibody FragmentsStelios Florinas, Marc Liu, Ryan Fleming, et al.
Mabs|March 6, 2019
Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimerJason B White, Ryan Fleming, Luke Masterson, et al.
Bioconjugate Chemistry|March 27, 2019
Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life ExtensionQing Li, Allison Barrett, Balakumar Vijayakrishnan, et al.
Mabs|February 5, 2014
The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamicsSiva Charan Devanaboyina, Sandra M Lynch, Raimund J Ober, et al.
Cancer Research|November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivoDowdy Jackson, John Gooya, Shenlan Mao, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumorsElizabeth M Bruckheimer, Christine A Fazenbaker, Sandra Gallagher, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2016
Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokineticsPamela Thompson, Ryan Fleming, Binyam Bezabeh, et al.
Bioconjugate Chemistry|August 6, 2019
A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with MaleimideAndre H St Amant, Fengying Huang, Jia Lin, et al.
Science Translational Medicine|November 14, 2014
A multifunctional bispecific antibody protects against Pseudomonas aeruginosaAntonio DiGiandomenico, Ashley E Keller, Cuihua Gao, et al.
Molecular Cancer Therapeutics|May 8, 2015
A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated PathwaysJonathan Rios-Doria, Darrin Sabol, Jon Chesebrough, et al.
Pageof 6